Breaking NewsUK Cannabis Firm GW Pharmaceuticals Honoured By Her Majesty...

UK Cannabis Firm GW Pharmaceuticals Honoured By Her Majesty For Its Innovation


LEADING UK cannabis company GW Pharmaceuticals has received the Queen’s Award for Enterprise 2021 in recognition of its ground-breaking work in creating the world’s first regulatory approved, prescription cannabis-based medicines.

Regarded as the highest official UK award for British business, the Queen’s Award for Enterprise is an annual award which recognises outstanding achievement in Innovation and is now in its 55th year. 

Formed in 1998, GW has successfully navigated significant barriers to enable the development, manufacture and commercialisation of regulatory approved cannabis-based medicines such a Sativex and Epidiolex, supporting tens of thousands of patients and families around the world. 

Supporting Patients

Most of its 1,100 staff are employed in the UK and over the years has invested over £1.3bn in the research, development and infrastructure needed to bring innovative medicines to patients. 

Dr Geoffrey Guy, Founder and Chairman said: “We are honoured to receive such a prestigious award for British businesses. When Dr Brian Whittle and I founded GW 23 years ago, our mission was to improve the lives of seriously ill patients by unlocking the potential of the cannabis plant through rigorous scientific investigations and extensive clinical trials in order to obtain regulatory approval for such medicines to benefit patients. 

“Today, I want to thank every employee, clinician, researcher, patient and caregiver for helping advance and achieve that mission.”

Earlier this year Irish firm Jazz Pharmaceuticals had a $7.2bn takeover bid for NASDAQ-listed GW accepted.

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.



Please enter your comment!
Please enter your name here

Latest news

Germany’s ‘KanaVape’ Moment As Police And Courts Crackdown On ‘Narcotic’ Hemp & CBD

TWO senior figures in the European cannabis industry are leading the fight against over-zealous German law enforcement in a...

UK CBD Consumption To Switch From Oils To Capsules – As New Research Estimates Market Value At £690m

CAPSULES are set to replace oils as the preferred method of CBD consumption - as new research show the...

Crowdfunding: An Emerging Capital Greenhouse For The Cannabis Industry

ALPHAGREEN is expected to hit close to the £2m crowdfunding mark on the Seedrs platform by mid-May – double...

Former JP Morgan Banker Lands Two UK Cannabis Jobs

A VETRAN of American investment bank JP Morgan has entered the burgeoning field of cannabis with appointments to two...

Europe’s Hemp Pioneer Posts Record Results With CBD, Construction And Car-Making To The Fore

EUROPEAN pioneer HempFlax has posted record annual results with revenues up 43% to €14.5m (£12.5m) as it returned a...

Sales Up Sharply At Sativa Wellness But Operational Costs Lead to £4.5m Loss

BRITISH CBD firm Sativa Wellness saw annual sales rise by over one-third in an eventful year which saw it...

Must read

Germany’s ‘KanaVape’ Moment As Police And Courts Crackdown On ‘Narcotic’ Hemp & CBD

TWO senior figures in the European cannabis industry are...

You might also likeRELATED
Recommended to you